ARWR•benzinga•
B. Riley Securities Reiterates Buy on Arrowhead Pharma, Lowers Price Target to $38
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 14, 2025 by benzinga